Company: PTPI
Filing Date: 2025-02-14
Form Type: S-1MEF
Source: 0001104659-25-014398
Chunk: 1

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-1MEF
Chunk 1
---
 amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.☐

Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

| Large accelerated filer |     | ¨ |     | Accelerated filer         |     | ¨ |
| Non-accelerated filer   |     | x |     | Smaller reporting company |     | x |
|                         |     |   |     | Emerging growth company   |     | x |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.☐

The Registration Statement shall become effective upon filing in accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended.

<div align='center'>EXPLANATORY NOTE AND INCORPORATION BY REFERENCE</div>

This Registration Statement is being filed by
Petros Pharmaceuticals, Inc., a Delaware corporation (the “Company”), pursuant to Rule 462(b) as promulgated
under the Securities Act of 1933, as amended (the “Securities Act”), and includes the registration statement facing page,
this page, the signature page, an exhibit index and the required opinion and consents for the sole purpose of increasing the proposed
maximum aggregate offering price of the securities offered by the Company by $1,600,000. This registration statement relates to the Company’s
registration statement on Form S-1 (File No. 333-284495), as amended (the “Prior Registration Statement”), declared
effective by the Securities and Exchange Commission on February 14, 2025. The contents of the Prior Registration Statement are incorporated